| Applications and limitations of dendrimers in biomedicine AA Chis, C Dobrea, C Morgovan, AM Arseniu, LL Rus, A Butuca, ... Molecules 25 (17), 3982, 2020 | 391 | 2020 |
| Nutrivigilance: A new activity in the field of dietary supplements C Morgovan, S Ghibu, AM Juncan, LL Rus, A Butucă, L Vonica, ... Farmacia 67 (3), 537-544, 2019 | 40 | 2019 |
| Dendrimers as non-viral vectors in gene-directed enzyme prodrug therapy AA Chis, CM Dobrea, LL Rus, A Frum, C Morgovan, A Butuca, M Totan, ... Molecules 26 (19), 5976, 2021 | 23 | 2021 |
| An exploratory research of 18 years on the economic burden of diabetes for the Romanian National Health Insurance System C Morgovan, SA Cosma, M Valeanu, AM Juncan, LL Rus, FG Gligor, ... International Journal of Environmental Research and Public Health 17 (12), 4456, 2020 | 22 | 2020 |
| Post-Marketing surveillance of statins—A descriptive analysis of psychiatric adverse reactions in EudraVigilance G Pop, A Farcaș, A Butucă, C Morgovan, AM Arseniu, M Pumnea, ... Pharmaceuticals 15 (12), 1536, 2022 | 21 | 2022 |
| A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database … BI Vintila, AM Arseniu, C Morgovan, A Butuca, M Sava, V Bîrluțiu, LL Rus, ... Pharmaceuticals 16 (11), 1585, 2023 | 18 | 2023 |
| Adverse drug reactions relevant to drug resistance and ineffectiveness associated with meropenem, linezolid, and colistin: an analysis based on spontaneous reports from the … BI Vintila, AM Arseniu, A Butuca, M Sava, V Bîrluțiu, LL Rus, DD Axente, ... Antibiotics 12 (5), 918, 2023 | 17 | 2023 |
| Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing A Frum, CM Dobrea, LL Rus, LI Virchea, C Morgovan, AA Chis, ... Nutrients 14 (15), 3065, 2022 | 17 | 2022 |
| Biopolymeric prodrug systems as potential antineoplastic therapy AA Chis, AM Arseniu, C Morgovan, CM Dobrea, A Frum, AM Juncan, ... Pharmaceutics 14 (9), 1773, 2022 | 14 | 2022 |
| Kinetic analysis of in vitro drug release from valproic acid and sodium valproate suppositories A Ciurba, N Todoran, A Tăurean, P Antonoaea, G Hancu, A Moisei, ... Farmacia 62 (6), 1143-1156, 2014 | 13 | 2014 |
| Compatibility and stability studies of antihypertensive/excipients by thermal methods, used in the preformulation phase A Moisei, F Gligor, M Bojiţă, A Chiş, M Totan, LA Vonica-Gligor, A Ciurba Farmacia 62 (6), 1239-1248, 2014 | 11 | 2014 |
| Safety profile of the trastuzumab-based ADCs: analysis of real-world data registered in EudraVigilance C Morgovan, CM Dobrea, A Butuca, AM Arseniu, A Frum, LL Rus, AA Chis, ... Biomedicines 12 (5), 953, 2024 | 9 | 2024 |
| A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection BI Vintila, AM Arseniu, C Morgovan, A Butuca, V Bîrluțiu, CM Dobrea, ... Antibiotics 13 (2), 144, 2024 | 9 | 2024 |
| The simultaneous determination of candesartan, amlodipine and hydrochlorothiazide by high-performance liquid chromatography, from a mixture and pharmaceutical formulations A Moisei, M Totan, FG Gligor, I Crăciun, N Todoran, AA Chiş, DE Popa Farmacia 4 (64), 612-618, 2016 | 9 | 2016 |
| Bîrlu t iu V., Rus LL, Ghibu S., Bereanu AS, Roxana Codru I., et al. A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides Difficile Infection … BI Vintila, AM Arseniu, C Morgovan, A Butuca, M Sava Pharmaceuticals 16 (1585), 10.3390, 2023 | 7 | 2023 |
| Primary packaging and stability evaluation of a serum used for the periorbital area of the sensitive eye AC Muntean, AM Juncan, DG Moisa, AL Vonica, LL Rus, C Morgovan, ... Mater. Plast 56, 360-365, 2019 | 6 | 2019 |
| Determination of Zn2+ in Solid Pharmaceutical Dosage Forms by Means of Spectrophotometry in Micellar Media: Method Validation LL Rus, AM Juncan, VI Crăciun, A Frum, SC Hegheș, A Butuca, ... Applied Sciences 12 (9), 4476, 2022 | 5 | 2022 |
| Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing. Nutrients. 2022; 14: 3065 A Frum, CM Dobrea, LL Rus, L Virchea, C Morgovan, AA Chis, A Arseniu, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published, 2022 | 4 | 2022 |
| The Descriptive and Disproportionality Assessment of EudraVigilance Database Reports on Capecitabine Induced Cardiotoxicity RC Vonica, A Butuca, AL Vonica-Tincu, C Morgovan, M Pumnea, ... Cancers 16 (22), 3847, 2024 | 3 | 2024 |
| An assessment of semaglutide safety based on real world data: from popularity to spontaneous reporting in Eudravigilance database A Butuca, CM Dobrea, AM Arseniu, A Frum, AA Chis, LL Rus, S Ghibu, ... Biomedicines 12 (5), 1124, 2024 | 3 | 2024 |